Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001390478-16-000095
Filing Date
2016-04-15
Accepted
2016-04-15 17:25:40
Documents
97
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A AMENDMENT NO. 2 copy2gale-20151231x10xka.htm 10-K/A 1139441
2 EXHIBIT 23.1 copy2gale-20151231xex231.htm EX-23.1 3048
3 EXHIBIT 31.1 copy2gale-20151231xex311.htm EX-31.1 8159
4 EXHIBIT 31.2 copy2gale-20151231xex312.htm EX-31.2 8172
5 EXHIBIT 32.1 copy2gale-20151231xex321.htm EX-32.1 6886
12 logo-verticala03.jpg GRAPHIC 21485
  Complete submission text file 0001390478-16-000095.txt   8658454

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gale-20151231.xml EX-101.INS 1866118
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20151231.xsd EX-101.SCH 88877
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20151231_cal.xml EX-101.CAL 115771
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20151231_def.xml EX-101.DEF 350975
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20151231_lab.xml EX-101.LAB 989126
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20151231_pre.xml EX-101.PRE 570148
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33958 | Film No.: 161575286
SIC: 2834 Pharmaceutical Preparations